Tirzepatide has two FDA-approved indications with distinct safety considerations
Suzuki and Ogra, 2002
| 05.15.26 | 12 min read
Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is an FDA-approved dual GIP/GLP-1 receptor agonist that reduces appetite and slows gastric emptying
Concerning the same, RichesM offers a vast range of organically made, certified, high-quality, and best price health supplements like Whey Protein, Multi-Vitamin tablets, Herbs, Mind & Wellness products, immunity booster, medical supplies, and all the important things to enhance one s own well-being
While semaglutide focuses on appetite regulation and glucose control, NAD works on cellular energy and repair